Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same

Details for Australian Patent Application No. 2010304091 (hide)

Owner LG Life Sciences Ltd.

Inventors Song, Jeong Uk; Kim, Geun Tae; Choi, Sung Pil; Jung, Cheol Kyu; Park, Deok Seong; Choi, Eun Sil; Kim, Tae Hun; Park, Hyun Jung; Park, Wan Su; Park, Heui Sul; Koo, Ki Chul; Artemov, Vasily

Agent Spruson & Ferguson

Pub. Number AU-A-2010304091

PCT Pub. Number WO2011/043568

Priority 10-2009-0095363 07.10.09 KR

Filing date 4 October 2010

Wipo publication date 14 April 2011

International Classifications

C07D 209/04 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/043568 Priority application(s): WO2011/043568

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010304095-Methods for power headroom reporting, resource allocation, and power control

2010304077-Method and apparatus for transmitting scheduling request signal in mobile communication system